Acute promyelocytic leukemia (APL) is a biologically and clinically distinct subtype of acute
myeloid leukemia (AML). APL is classified as AML-M3 in the French-American-British (FAB) …

Conventional/molecular cytogenetics is important in identification of genomic abnormalities,
for prognostication and in risk stratification of de novo patients with acute myeloid leukemias …

To the Editor, A diagnosis of t (9; 22)/BCR-ABL1 positive chronic myeloid leukaemia (CML)
is often considered as the most common differential diagnosis in a patient with massive …

Because an increasing number of chromosomal aberrations have been detected in the
patients with acute leukemia, cytogenetic findings have become more valuable in …

Thirty cases of acute myeloid leukaemia (AML) with MYST histone acetyltransferase 3
(MYST3) rearrangement were collected in a retrospective study from 14 centres in France …

The t (2; 11)(p21; q23) is a rare aberration described in~ 20 cases of myelodysplastic
syndrome (MDS) and de novo acute leukemia (myelocytic or lymphocytic) or following an …

A 55-year-old man was admitted to our hospital because of worsening pancytopenia and
increasing blast cells in peripheral blood. The patient had a fourteen-year history of IgM …

Background Acute myeloid leukemia (AML) comprises a spectrum of myeloid malignancies
which are often associated with distinct chromosomal abnormalities, and the analysis of …

Key Clinical Message t (11; 17) is a rare but recognized finding usually found in Acute
Promyelocytic Leukemia with variant RARA translocation (APLv). We present a case of …

Acute myeloblastic leukemia (AML) with t (8: 16) or its variant t (8: V) has been rarely
reported. A high proportion of patients are infants and children, often with a bleeding …